N60T (p.Asn60Thr) variant of SGCD (Delta-sarcoglycan)
N60T (p.Asn60Thr) in SGCD (Delta-sarcoglycan) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.79 / 1. The record also includes structural context.
N60T (p.Asn60Thr) variant details
- p.Asn60Thr
- NCI-TCGA Cosmic COSV6191
- cosmic curated COSV61918
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.789
- ESM-1b 1.00
- AlphaMissense 0.54
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available